England’s Revised Childhood Vaccine Schedule Linked to Widening Immunity Gap in Deprived Communities

Widening inequality in England's childhood PCV booster uptake follows a shift to the 1+1 schedule, leaving deprived areas at higher risk of pneumococcal disease.

By: AXL Media

Published: Apr 7, 2026, 9:03 AM EDT

Source: Information for this report was sourced from News-Medical.net

The Shift from 2+1 to 1+1 Vaccination Strategy

In 2020, England became the only European nation to transition its pneumococcal conjugate vaccine (PCV) strategy from a "2+1" schedule to a "1+1" schedule. This change replaced the traditional two primary doses (at 8 and 16 weeks) and a 12-month booster with a single primary dose at 12 weeks followed by the 12-month booster. While initial immunogenicity studies suggested the new schedule offered comparable protection, its long-term success was entirely dependent on maintaining high and timely booster uptake. However, new data suggests this transition, occurring alongside the disruptions of the COVID-19 pandemic, has led to unintended gaps in national immunity.

National Booster Coverage Falls Below WHO Targets

Pediatric vaccine uptake across England has seen a steady decline since 2019. National PCV booster coverage at 24 months, which peaked at 92.5% in the 2012-13 period, fell to 88.2% by 2023-24. This figure remains significantly below the World Health Organization (WHO) target of 95%. Under the previous 2+1 schedule, the mean gap between primary dose uptake and booster coverage was 2.32%. Following the revision to the 1+1 schedule, this gap widened to 4.79%, indicating that a growing number of children are missing the critical second dose required for long-term protection against Streptococcus pneumoniae.

Widening Inequality Between Social Strata

The decline in booster retention has disproportionately affected England’s most vulnerable populations. According to deprivation index data, the inequality gap in PCV booster coverage between the least and most deprived quintiles has doubled, rising from approximately 2-3% before 2020 to 4-6% in the post-revision era. London, characterized by a distinct demographic profile, exhibited particularly low booster retention. In certain areas of the capital, such as Hackney, booster coverage plummeted to a nadir of 65.5%, a sharp contrast to the more affluent local authorities that maintained higher, though still declining, rates.